|
2024
|
Invention
|
Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-c... |
|
|
Invention
|
Piperidine derivatives as mettl3 inhibitors. 2 are as defined as disclosed, which are useful as i... |
|
|
Invention
|
Piperidine derivatives as mettl3 inhibitors. The present invention relates to compounds of formul... |
|
2023
|
Invention
|
Polymorphs of (2s,5r)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-c... |
|
2021
|
Invention
|
Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4- carbonyl)pyrrolidine-2-c... |
|
|
Invention
|
Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-ca... |
|
2020
|
Invention
|
Substituted pyrrolidines as g-protein coupled receptor 43 agonists. The present invention is dire... |
|
2014
|
Invention
|
Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases. Comp... |
|
|
Invention
|
Organic compounds. The present invention relates to modulators of the interaction between G-prote... |
|
2003
|
Invention
|
Ligand for g-protein coupled receptor gpr43 and uses thereof. The present invention is related to... |
